The choice of the Resona A20 as the official hands‑on training system underscored ECR’s commitment to meaningful technological innovation. Its presence on the congress floor brought this year’s theme, “Rays of Knowledge,” into sharp focus—a concept Congress President Prof. Minerva Becker described during the opening ceremony as “not merely technological progress, but a transformation in education and clinical thinking.”
At the Mindray pavilion, this revolution materialized into the ability to visualize microvascular architecture with breathtaking clarity. A distinguished doctor, after experiencing the A20 firsthand, marveled: "In Mindray's images, we can now trace microvascular patterns once visible only in pathological specimens. This is not merely equipment evolution — it is a new window into understanding disease itself."
Since its domestic launch in 2023, the Resona A20 has secured CE and FDA certifications, earning acclaim in core global markets. The system has rapidly penetrated premium healthcare segments across Europe and the Middle East. In Europe alone, its superior resolution and image quality have secured placements at prestigious institutions including the Royal Infirmary of Edinburgh and Germany's Regensburg University Hospital (UKR).
The congress witnessed another milestone in Mindray's academic journey — the deepening of its strategic partnership with UKR and the inauguration of the "m-Elite Global Ultrasound Training Center," a groundbreaking international academic exchange initiative.
Director of Radiology at Regensburg University Hospital
Ultrasound medicine is an art of practice, where mentorship is paramount. Through the m-Elite program, we aspire to amplify Regensburg's clinical expertise via advanced remote platforms. This transcends technology transfer — it is the democratization of knowledge, bringing frontier healthcare within everyone's reach.
The bond between UKR's Interdisciplinary Ultrasound Center and Mindray spans years of joint endeavors. Beyond organizing academic exchanges, the partners have pioneered research applying Mindray's microvascular contrast imaging and multi-parameter fusion analysis to diagnostics of the liver, lung, and thyroid. United by a shared vision, they continue advancing ultrasound innovation for earlier cancer detection and improved patient outcomes.
Under the leadership of Prof. Stroszczynski and Prof. Ernst-Michael Jung, UKR's research program translates sophisticated imaging into tangible clinical benefits for cancer patients — spanning multi-parametric tissue characterization of the liver, spleen, kidney, bowel, thyroid, breast, lymph nodes, and soft tissue tumors. This work drives diagnostic threshold validation and standardization across these critical domains.
From "Rays of Knowledge" to "Envision Next — See beyond, reach beyond", Mindray has articulated its aspiration for medical progress through robust innovation, compassionate healthcare vision, and open collaboration across industry, academia, and research. On the prestigious stage of ECR, Mindray demonstrated its commitment to shaping a borderless, intelligent, and human-centered healthcare ecosystem — standing as a formidable guardian of global human health.The future beckons. Mindray answers the call.